These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7843470)

  • 1. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.
    Campbell IW; Menzies DG; Chalmers J; McBain AM; Brown IR
    Diabete Metab; 1994; 20(4):394-400. PubMed ID: 7843470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Body mass index, blood lactate and therapeutic effectiveness of metformin in type II diabetes mellitus].
    Gregorio F; Ambrosi F; Angelici F; Cristallini S; Dini FL; Vespasiani G; Santeusanio F; Filipponi P
    Medicina (Firenze); 1989; 9(2):200-4. PubMed ID: 2682123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
    De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
    J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
    Saxena T; Maheshwari S; Goyal RK
    J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is metformin safe enough for ageing type 2 diabetic patients?
    Gregorio F; Ambrosi F; Filipponi P; Manfrini S; Testa I
    Diabetes Metab; 1996 Feb; 22(1):43-50. PubMed ID: 8697295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects.
    Liu GC; Coulston AM; Lardinois CK; Hollenbeck CB; Moore JG; Reaven GM
    Arch Intern Med; 1985 Apr; 145(4):665-9. PubMed ID: 3885889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of treatment with glipizide-metformin on the behavior of blood sugar, insulin and lipids after intravenous administration of glucose in diabetic subjects].
    Ferlito S; Lunetta M; Mangiagli P; Tranchida ML
    G Clin Med; 1974 Nov; 55(11):798-818. PubMed ID: 4469884
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes.
    Teupe B; Bergis K
    Diabete Metab; 1991 May; 17(1 Pt 2):213-7. PubMed ID: 1936479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metformin therapy on plasma amino acid pattern in patients with maturity-onset diabetes.
    Marchetti P; Masiello P; Benzi L; Cecchetti P; Fierabracci V; Giannarelli R; Gregorio F; Brunetti P; Navalesi R
    Drugs Exp Clin Res; 1989; 15(11-12):565-70. PubMed ID: 2637797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profiling reveals different therapeutic effects of metformin and glipizide in patients with type 2 diabetes and coronary artery disease.
    Zhang Y; Hu C; Hong J; Zeng J; Lai S; Lv A; Su Q; Dong Y; Zhou Z; Tang W; Zhao J; Cui L; Zou D; Wang D; Li H; Liu C; Wu G; Shen J; Zhu D; Wang W; Shen W; Ning G; Xu G
    Diabetes Care; 2014 Oct; 37(10):2804-12. PubMed ID: 25011952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alteration of blood lactic acid levels in biguanide therapy in diabetics].
    Yang DP; Liang JZ; Luo ZT
    Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):162-5. PubMed ID: 3939266
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes.
    McBain AM; Brown IR; Menzies DG; Campbell IW
    J Clin Pathol; 1988 Sep; 41(9):933-5. PubMed ID: 3192752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.
    Cefalu WT; Schneider DJ; Carlson HE; Migdal P; Gan Lim L; Izon MP; Kapoor A; Bell-Farrow A; Terry JG; Sobel BE
    Diabetes Care; 2002 Dec; 25(12):2123-8. PubMed ID: 12453948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycemic equilibrium and weight evolution in diabetics taking metformin].
    Isnard F; André P
    Journ Annu Diabetol Hotel Dieu; 1991; ():297-314. PubMed ID: 1832200
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Srinivasan S; Kaur V; Chamarthi B; Littleton KR; Chen L; Manning AK; Merino J; Thomas MK; Hudson M; Goldfine A; Florez JC
    Diabetes Care; 2018 Mar; 41(3):554-561. PubMed ID: 29326107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved glucose control decreases the interaction of plasma low-density lipoproteins with arterial proteoglycans.
    Edwards IJ; Terry JG; Bell-Farrow AD; Cefalu WT
    Metabolism; 2002 Oct; 51(10):1223-9. PubMed ID: 12370838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.